Cisplatin: From DNA damage to cancer chemotherapy
Top Cited Papers
- 1 January 2001
- book chapter
- Published by Elsevier in Progress in Nucleic Acid Research and Molecular Biology
- Vol. 67, 93-130
- https://doi.org/10.1016/s0079-6603(01)67026-0
Abstract
No abstract availableKeywords
This publication has 122 references indexed in Scilit:
- The Hallmarks of CancerCell, 2000
- Cellular and molecular determinants of cisplatin resistanceEuropean Journal Of Cancer, 1998
- NMR Solution Structure of a DNA Dodecamer Duplex Containing a cis-Diammineplatinum(II) d(GpG) Intrastrand Cross-Link, the Major Adduct of the Anticancer Drug CisplatinBiochemistry, 1998
- Differential Binding of HMG1, HMG2, and a Single HMG Box to Cisplatin-Damaged DNAToxicology and Applied Pharmacology, 1996
- How Proteins Recognize the TATA BoxJournal of Molecular Biology, 1996
- Binding of Ixr1, a Yeast HMG-Domain Protein, to Cisplatin−DNA Adducts in Vitro and in VivoBiochemistry, 1996
- Specific Association of Human Telomerase Activity with Immortal Cells and CancerScience, 1994
- Crystal structure of a yeast TBP/TATA-box complexNature, 1993
- Characterization of high mobility group protein binding to cisplatin-damaged DNABiochemical and Biophysical Research Communications, 1992
- Cis-Pt(NH3)2Cl2 and trans-Pt(NH3)2Cl2 inhibit DNA synthesis in cultured L1210 leukemia cellsBiochemical and Biophysical Research Communications, 1983